Health - Google News: Biogen and Isis will study muscular dystrophy drug

Saturday, June 30, 2012

Health - Google News

Google News

Jun 29th 2012, 18:15

Biogen and Isis will study muscular dystrophy drug
CBS News
NEW YORK — Biogen Idec Inc. and Isis Pharmaceuticals Inc. said Friday they will work together to develop a treatment for the most common type of muscular dystrophy in adults. Biogen agreed to pay Isis $12 million upfront. The Carlsbad, Calif., company ...
Biogen, Isis announce Steinert disease drug collaborationBoston Herald
Biogen, Isis in deal worth up to $271MMass High Tech
Biogen Idec offers up to $271M for its second Isis pactFierceBiotech
Boston Globe
all 28 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in:

Paparazziii